Weekly epirubicin plus tamoxifen versus tamoxifen alone as adjuvant treatment of operable, node-positive, elderly breast cancer patients - Reply

被引：1

作者：

Fargeot, P ^{[1
]}

机构：

[1] Ctr Georges Francois Leclerc, Dept Med Oncol, Dijon, France

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 18期

关键词：

D O I：

10.1200/JCO.2005.01.2286

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：4238 / 4239

页数：2

共 6 条

[1] Undertreatment strongly decreases prognosis of breast cancer in elderly women
Bouchardy, C
Rapiti, E
Fioretta, G
Laissue, P
Neyroud-Caspar, I
Schäfer, P
Kurtz, J
Sappino, AP
Vlastos, G
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (19) : 3580 - 3587
[2] Clarke M, 1998, LANCET, V351, P1451
[3] Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer:: The International Breast Cancer Study Group Trial VII
Crivellari, D
Bonetti, M
Castiglione-Gertsch, M
Gelber, RD
Rudenstam, CM
Thürlimann, B
Price, KN
Coates, AS
Hürny, C
Bernhard, J
Lindtner, J
Collins, J
Senn, HJ
Cavalli, F
Forbes, J
Gudgeon, A
Simoncini, E
Cortes-Funes, H
Veronesi, A
Fey, M
Goldhirsch, A
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (07) : 1412 - 1422
[4] Older age predicts a decline in adjuvant chemotherapy recommendations for patients with breast carcinoma - Evidence from a tertiary care cohort of chemotherapy-eligible patients
DeMichele, A
Putt, M
Zhang, YW
Glick, JH
Norman, S
[J]. CANCER, 2003, 97 (09) : 2150 - 2159
[5] CYCLOPHOSPHAMIDE, METHOTREXATE, AND 5-FLUOROURACIL CHEMOTHERAPY IN WOMEN MORE THAN 65 YEARS OLD WITH ADVANCED BREAST-CANCER - THE ELIMINATION OF AGE TRENDS IN TOXICITY BY USING DOSES BASED ON CREATININE CLEARANCE
GELMAN, RS
TAYLOR, SG
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (12) : 1404 - 1413
[6] Breast cancer treatment guidelines in older women
Giordano, SH
Hortobagyi, GN
Kau, SWC
Theriault, RL
Bondy, ML
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (04) : 783 - 791

← 1 →